Second annual assembly, sponsored by the Department of Biology and Picower Institute, invited postdocs from across the country to meet with faculty, present their work to the MIT community, and build relationships.
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.
Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.
Team-based targeted projects, multi-mentor fellowships ensure that scientists studying social cognition, behavior, and autism integrate multiple perspectives and approaches to pressing questions.
Roger Levy, Pulin Li, and David McGee were nominated by peers and students for their exceptional instruction.
Researchers are working to advance the field of glycoscience, illuminating the essential role of carbohydrates for human health and disease.
Glyco enthusiasts from MIT and beyond recently gathered in Bartos Theatre to enjoy presentations of the latest advancements in glycobiology research.
Faculty members were recently granted tenure in the departments of Biology, Brain and Cognitive Sciences, Chemistry, EAPS, and Physics.
MIT PhD student Kathrin Kajderowicz is studying how hibernation-like states could pave the way for new hypothermic therapies.
Whitehead Institute researchers find many transcription factors bind RNA, which fine-tunes their regulation of gene expression, suggesting new therapeutic opportunities.
A new approach for identifying significant differences in gene use between closely-related species provides insights into human evolution.
Catalyst Symposium is part of an effort to bring outstanding postdocs from underrepresented backgrounds in science to engage with MIT community members.
Matt Shoulders will lead an interdisciplinary team to improve RuBisCO — the photosynthesis enzyme thought to be the holy grail for improving agricultural yield.
Fellowship funds graduate studies for outstanding immigrants and children of immigrants.
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.